Results 111 to 120 of about 990 (199)

Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis

, 2020
Hyperprolactinemia (hPRL) often poses a diagnostic dilemma due to the presence of macroprolactin. Understanding the prevalence of macroprolactinemia (mPRL) has an important implication in managing patients with hPRL.
Anis Kausar Ghazali, Noor Azlin Azraini Che Soh, Noorazliyana Shafii, Tuan Salwani Tuan Ismail, Wan Norlina Wan Azman, Julia Omar, Aniza Mohammed Jelani, Najib Majdi Yaacob   +7 more
core   +1 more source

Long-term proton pump inhibitors therapy and prevalence of hyperprolactinemia. a cross-sectional study in outpatient gastroenterology clinics

Journal of the Pakistan Medical Association
Objective: To evaluate serum prolactin and macroprolactin levels in patients on long-term proton pump inhibitors therapy. Method: The cross-sectional study was conducted from January 2018 to November 2019 after approval from the ethics review ...
Muhammad Ashfaq, Adil Naseer Khan, Yasser MSA Alkahraman, Muhammad Zeeshan Haroon   +3 more
doaj   +1 more source

The Macroprolactin Problem [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2002
openaire   +1 more source

Macroprolactinaemia in a 33-year old premenopausal Nigerian woman: a case report

, 2017
Background: Macroprolactin is a 150-170kDa heteropolymeric complex of monomeric prolactin and immunoglobulin G (IgG) that contributes less than 1% of circulating prolactin concentration in plasma. It exerts little or no biological action in vivo.
Okpara, H.C., Agan, T.U., Ekanem, E.C., Enang, O.E., Akpan, U.B.   +4 more
core   +1 more source

Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin

Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin
The clinical influence of macroprolactin (MPRL) is not clearly understood and the rate of patients potentially affected by MPRL is unknown. We investigated the influence of MPRL on the onset of galactorrhea and estimated the rate of patients with a proportion of MPRL fraction that may possibly affect galactorrhea.
openaire  

ASSAYING OF MACROPROLACTINE IN ASSESMENT OF HYPERPROLACTINEMIA

, 2017
UVOD: Prolaktin je polipeptidni hormon kojeg izlučuje adenohipofiza. Različiti molekularni oblici prolaktina u cirkulaciji utječu na njegovu biološku aktivnost.
Kalajžić, Nina
core  

The significance of prolactin in systemic connective tissue diseases. [PDF]

Reumatologia, 2023
Jakubaszek MP.
europepmc   +1 more source

Position statement on macroprolactinemia from the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML). [PDF]

Arch Endocrinol Metab
Glezer A, Elias PCL, Nogueira VDSN, Garmes HM, Kasuki L, Rollin GAFS, Martins MRA, Leme AC, Rosa PS, Naves LA, Batista MC.   +10 more
europepmc   +1 more source

Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications. [PDF]

Nutrients
Krysiak R, Kowalcze K, Cangelosi G, Deledda A, Okopień B.   +4 more
europepmc   +1 more source

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome. [PDF]

J Clin Med, 2023
Krysiak R, Kowalcze K, Szkróbka W, Okopień B.   +3 more
europepmc   +1 more source